MedPath

BANZEL

BANZEL

Approved
DIN Number

02369648

Drug Class

Human

Market Date

Sep 1, 2011

Company
HC

EISAI LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02369648
AIG Number0152938003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF03 RUFINAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

RUFINAMIDEActive
Strength: 400 MG
Monograph: RUFINAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.